DME Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.3M | Sell |
4,551,057
-890,110
| -16% | -$10M | 2.21% | 16 |
|
|
2025
Q1 | $54.9M | Buy |
5,441,167
+170,100
| +3% | +$1.72M | 2.78% | 12 |
|
|
2024
Q4 | $62.4M | Sell |
5,271,067
-36,973
| -0.7% | -$437K | 3.21% | 10 |
|
|
2024
Q3 | $61.3M | Buy |
5,308,040
+497,080
| +10% | +$5.74M | 2.55% | 11 |
|
|
2024
Q2 | $50.9M | Buy |
4,810,960
+620,470
| +15% | +$6.56M | 2.49% | 12 |
|
|
2024
Q1 | $44.2M | Buy |
+4,190,490
| New | +$44.2M | 2.02% | 16 |
|